-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Gain Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2023.
- Gain Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$3.59M, a 15% increase year-over-year.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$18.9M, a 28.4% decline from 2022.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$14.7M, a 18.8% decline from 2021.
- Gain Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$12.4M, a 282% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)